Renalytix (RENX) Stock Chart & Stock Price History GBX 7.75 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Renalytix Stock Price Performance 5 Day Performance+3.33%1 Month Performance-3.13%3 Month Performance-46.55%6 Month Performance-66.30%Year-To-Date Performance-50.00%1 Year Performance-67.74% Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide RENX Stock Chart for Sunday, November, 17, 2024 RENX Chart by TradingView Renalytix Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024GBX 7.50GBX 8+6.67%GBX 8GBX 7.50228,209 shs£13.27 million11/14/2024GBX 7.50GBX 7.50GBX 8GBX 7.50113,035 shs£12.45 million11/13/2024GBX 7.50GBX 7.50GBX 8GBX 7.50257,538 shs£12.45 million11/12/2024GBX 7.50GBX 7.50GBX 8.50GBX 7.50355,457 shs£12.45 million11/11/2024GBX 8.50GBX 7.50-11.76%GBX 8.50GBX 7.50386,524 shs£12.45 million11/08/2024GBX 8GBX 8.50+6.25%GBX 8.50GBX 7.88109,880 shs£14.10 million Get the Latest News and Ratings for RENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024GBX 7.48GBX 8+6.95%GBX 8.50GBX 7.5061,598 shs£13.27 million11/06/2024GBX 8.50GBX 7.48-11.95%GBX 8.18GBX 7.4822.62 million shs£12.41 million11/05/2024GBX 8.50GBX 8.50-0.06%GBX 8.50GBX 7.65522,917 shs£14.10 million11/04/2024GBX 8GBX 8.50+6.25%GBX 8.50GBX 8.50297,665 shs£14.10 million11/01/2024GBX 8GBX 7.55-5.63%GBX 8GBX 7.5528,909 shs£12.53 million10/31/2024GBX 7.85GBX 8+1.91%GBX 8GBX 897,526 shs£13.27 million10/30/2024GBX 8.20GBX 7.85-4.27%GBX 8.50GBX 7.50282,153 shs£13.03 million10/29/2024GBX 8.50GBX 8.20-3.53%GBX 8.50GBX 7.801.12 million shs£13.61 million10/28/2024GBX 8GBX 8.50+6.25%GBX 8.50GBX 8.251.05 million shs£14.10 million10/25/2024GBX 8.48GBX 8.25-2.65%GBX 8.50GBX 8172,533 shs£13.69 million10/24/2024GBX 7.75GBX 8.48+9.35%GBX 8.50GBX 7.50182,612 shs£14.06 million10/23/2024GBX 7.41GBX 7.75+4.57%GBX 7.75GBX 7.32122,238 shs£12.86 million10/22/2024GBX 7.70GBX 7.41-3.75%GBX 8GBX 7.416,953 shs£12.30 million10/21/2024GBX 7.50GBX 7.70+2.67%GBX 8GBX 7.20339,698 shs£12.78 million10/18/2024GBX 8GBX 7.41-7.36%GBX 7.63GBX 7.41293,421 shs£12.30 million10/17/2024GBX 7.38GBX 8+8.40%GBX 8GBX 7.38315,438 shs£13.27 million10/16/2024GBX 7.38GBX 7.38GBX 8GBX 7.38318,615 shs£12.25 million Related Companies Cambridge Cognition Stock Chart Induction Healthcare Group Stock Chart Feedback Stock Chart IQ-AI Stock Chart Trellus Health Stock Chart Craneware Stock Chart Kooth Stock Chart Venture Life Group Stock Chart ECO Animal Health Group Stock Chart Poolbeg Pharma Stock Chart Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. This page (LON:RENX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
